» Articles » PMID: 11292668

Involvement of Rho-kinase in Hypertensive Vascular Disease: a Novel Therapeutic Target in Hypertension

Overview
Journal FASEB J
Specialties Biology
Physiology
Date 2001 Apr 9
PMID 11292668
Citations 73
Authors
Affiliations
Soon will be listed here.
Citing Articles

Rho-kinase inhibition reduces systolic blood pressure and forearm vascular resistance in healthy older adults: a double-blind, randomized, placebo-controlled pilot study.

Bachman N, Ketelhut N, Blomquist M, Terwoord J Geroscience. 2024; 46(6):6317-6329.

PMID: 38888876 PMC: 11494619. DOI: 10.1007/s11357-024-01240-x.


Vascular Inflammation and Smooth Muscle Contractility: The Role of Nox1-Derived Superoxide and LRRC8 Anion Channels.

Lamb F, Choi H, Miller M, Stark R Hypertension. 2024; 81(4):752-763.

PMID: 38174563 PMC: 10954410. DOI: 10.1161/HYPERTENSIONAHA.123.19434.


Selective ROCK Inhibitor Enhances Blood Flow Recovery after Hindlimb Ischemia.

Fayed H, Bakleh M, Ashraf J, Howarth A, Ebner D, Al Haj Zen A Int J Mol Sci. 2023; 24(19).

PMID: 37833857 PMC: 10572734. DOI: 10.3390/ijms241914410.


Pharmacotherapy in patients with vasomotor disorders.

Boerhout C, Feenstra R, van de Hoef T, Piek J, Beijk M Int J Cardiol Heart Vasc. 2023; 48:101267.

PMID: 37727753 PMC: 10505589. DOI: 10.1016/j.ijcha.2023.101267.


Mechanisms of Coronary Artery Spasm.

Nishimiya K, Takahashi J, Oyama K, Matsumoto Y, Yasuda S, Shimokawa H Eur Cardiol. 2023; 18:e39.

PMID: 37456775 PMC: 10345984. DOI: 10.15420/ecr.2022.55.